Market Research Report

ADAM10 Antibody Market, Global Outlook and Forecast 2023-2029

  • AMR ID : 7-3114
  • CAT ID : 7
  • Pages : 146
  • Date : Jun 2023
 

The global ADAM10 Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Growing patient base, launch of novel ADAM10 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in ADAM10 antibody market revenue.
ADAM10 Antibody is a mouse, rabbit, porcine and human antibody against ADAM10. ADAM10 was recognized in immunohistochemical staining and western blotting.
This report aims to provide a comprehensive presentation of the global market for ADAM10 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADAM10 Antibody. This report contains market size and forecasts of ADAM10 Antibody in global, including the following market information:
Global ADAM10 Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the ADAM10 Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ADAM10 Antibody Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global ADAM10 Antibody Market Segment Percentages, by Type, 2022 (%)
Monoclonal
Polyclonal
Global ADAM10 Antibody Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global ADAM10 Antibody Market Segment Percentages, by Application, 2022 (%)
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Global ADAM10 Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global ADAM10 Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies ADAM10 Antibody revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies ADAM10 Antibody revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
LifeSpan BioSciences
Thermo Fisher Scientific
QED Bioscience
BosterBio
NSJ Bioreagents
EpiGentek
GeneTex
Cell Signaling Technology
RayBiotech
HUABIO
ProSci
Novus Biologicals
R and D Systems
Alomone Labs
Affinity Biosciences
Proteintech Group
Miltenyi Biotec
Enzo Life Sciences
Biobyt
Sino Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of ADAM10 Antibody, market overview.
Chapter 2: Global ADAM10 Antibody market size in revenue.
Chapter 3: Detailed analysis of ADAM10 Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of ADAM10 Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
1.1 ADAM10 Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global ADAM10 Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global ADAM10 Antibody Overall Market Size
2.1 Global ADAM10 Antibody Market Size: 2022 VS 2029
2.2 Global ADAM10 Antibody Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top ADAM10 Antibody Players in Global Market
3.2 Top Global ADAM10 Antibody Companies Ranked by Revenue
3.3 Global ADAM10 Antibody Revenue by Companies
3.4 Top 3 and Top 5 ADAM10 Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies ADAM10 Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 ADAM10 Antibody Players in Global Market
3.6.1 List of Global Tier 1 ADAM10 Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 ADAM10 Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global ADAM10 Antibody Market Size Markets, 2022 & 2029
4.1.2 Monoclonal
4.1.3 Polyclonal
4.2 By Type - Global ADAM10 Antibody Revenue & Forecasts
4.2.1 By Type - Global ADAM10 Antibody Revenue, 2018-2023
4.2.2 By Type - Global ADAM10 Antibody Revenue, 2024-2029
4.2.3 By Type - Global ADAM10 Antibody Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global ADAM10 Antibody Market Size, 2022 & 2029
5.1.2 Immunochemistry (IHC)
5.1.3 Immunofluorescence (IF)
5.1.4 Immunoprecipitation (IP)
5.1.5 Western Blot (WB)
5.1.6 ELISA
5.1.7 Others
5.2 By Application - Global ADAM10 Antibody Revenue & Forecasts
5.2.1 By Application - Global ADAM10 Antibody Revenue, 2018-2023
5.2.2 By Application - Global ADAM10 Antibody Revenue, 2024-2029
5.2.3 By Application - Global ADAM10 Antibody Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global ADAM10 Antibody Market Size, 2022 & 2029
6.2 By Region - Global ADAM10 Antibody Revenue & Forecasts
6.2.1 By Region - Global ADAM10 Antibody Revenue, 2018-2023
6.2.2 By Region - Global ADAM10 Antibody Revenue, 2024-2029
6.2.3 By Region - Global ADAM10 Antibody Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America ADAM10 Antibody Revenue, 2018-2029
6.3.2 US ADAM10 Antibody Market Size, 2018-2029
6.3.3 Canada ADAM10 Antibody Market Size, 2018-2029
6.3.4 Mexico ADAM10 Antibody Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe ADAM10 Antibody Revenue, 2018-2029
6.4.2 Germany ADAM10 Antibody Market Size, 2018-2029
6.4.3 France ADAM10 Antibody Market Size, 2018-2029
6.4.4 U.K. ADAM10 Antibody Market Size, 2018-2029
6.4.5 Italy ADAM10 Antibody Market Size, 2018-2029
6.4.6 Russia ADAM10 Antibody Market Size, 2018-2029
6.4.7 Nordic Countries ADAM10 Antibody Market Size, 2018-2029
6.4.8 Benelux ADAM10 Antibody Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia ADAM10 Antibody Revenue, 2018-2029
6.5.2 China ADAM10 Antibody Market Size, 2018-2029
6.5.3 Japan ADAM10 Antibody Market Size, 2018-2029
6.5.4 South Korea ADAM10 Antibody Market Size, 2018-2029
6.5.5 Southeast Asia ADAM10 Antibody Market Size, 2018-2029
6.5.6 India ADAM10 Antibody Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America ADAM10 Antibody Revenue, 2018-2029
6.6.2 Brazil ADAM10 Antibody Market Size, 2018-2029
6.6.3 Argentina ADAM10 Antibody Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa ADAM10 Antibody Revenue, 2018-2029
6.7.2 Turkey ADAM10 Antibody Market Size, 2018-2029
6.7.3 Israel ADAM10 Antibody Market Size, 2018-2029
6.7.4 Saudi Arabia ADAM10 Antibody Market Size, 2018-2029
6.7.5 UAE ADAM10 Antibody Market Size, 2018-2029
7 ADAM10 Antibody Companies Profiles
7.1 LifeSpan BioSciences
7.1.1 LifeSpan BioSciences Company Summary
7.1.2 LifeSpan BioSciences Business Overview
7.1.3 LifeSpan BioSciences ADAM10 Antibody Major Product Offerings
7.1.4 LifeSpan BioSciences ADAM10 Antibody Revenue in Global Market (2018-2023)
7.1.5 LifeSpan BioSciences Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific ADAM10 Antibody Major Product Offerings
7.2.4 Thermo Fisher Scientific ADAM10 Antibody Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 QED Bioscience
7.3.1 QED Bioscience Company Summary
7.3.2 QED Bioscience Business Overview
7.3.3 QED Bioscience ADAM10 Antibody Major Product Offerings
7.3.4 QED Bioscience ADAM10 Antibody Revenue in Global Market (2018-2023)
7.3.5 QED Bioscience Key News & Latest Developments
7.4 BosterBio
7.4.1 BosterBio Company Summary
7.4.2 BosterBio Business Overview
7.4.3 BosterBio ADAM10 Antibody Major Product Offerings
7.4.4 BosterBio ADAM10 Antibody Revenue in Global Market (2018-2023)
7.4.5 BosterBio Key News & Latest Developments
7.5 NSJ Bioreagents
7.5.1 NSJ Bioreagents Company Summary
7.5.2 NSJ Bioreagents Business Overview
7.5.3 NSJ Bioreagents ADAM10 Antibody Major Product Offerings
7.5.4 NSJ Bioreagents ADAM10 Antibody Revenue in Global Market (2018-2023)
7.5.5 NSJ Bioreagents Key News & Latest Developments
7.6 EpiGentek
7.6.1 EpiGentek Company Summary
7.6.2 EpiGentek Business Overview
7.6.3 EpiGentek ADAM10 Antibody Major Product Offerings
7.6.4 EpiGentek ADAM10 Antibody Revenue in Global Market (2018-2023)
7.6.5 EpiGentek Key News & Latest Developments
7.7 GeneTex
7.7.1 GeneTex Company Summary
7.7.2 GeneTex Business Overview
7.7.3 GeneTex ADAM10 Antibody Major Product Offerings
7.7.4 GeneTex ADAM10 Antibody Revenue in Global Market (2018-2023)
7.7.5 GeneTex Key News & Latest Developments
7.8 Cell Signaling Technology
7.8.1 Cell Signaling Technology Company Summary
7.8.2 Cell Signaling Technology Business Overview
7.8.3 Cell Signaling Technology ADAM10 Antibody Major Product Offerings
7.8.4 Cell Signaling Technology ADAM10 Antibody Revenue in Global Market (2018-2023)
7.8.5 Cell Signaling Technology Key News & Latest Developments
7.9 RayBiotech
7.9.1 RayBiotech Company Summary
7.9.2 RayBiotech Business Overview
7.9.3 RayBiotech ADAM10 Antibody Major Product Offerings
7.9.4 RayBiotech ADAM10 Antibody Revenue in Global Market (2018-2023)
7.9.5 RayBiotech Key News & Latest Developments
7.10 HUABIO
7.10.1 HUABIO Company Summary
7.10.2 HUABIO Business Overview
7.10.3 HUABIO ADAM10 Antibody Major Product Offerings
7.10.4 HUABIO ADAM10 Antibody Revenue in Global Market (2018-2023)
7.10.5 HUABIO Key News & Latest Developments
7.11 ProSci
7.11.1 ProSci Company Summary
7.11.2 ProSci Business Overview
7.11.3 ProSci ADAM10 Antibody Major Product Offerings
7.11.4 ProSci ADAM10 Antibody Revenue in Global Market (2018-2023)
7.11.5 ProSci Key News & Latest Developments
7.12 Novus Biologicals
7.12.1 Novus Biologicals Company Summary
7.12.2 Novus Biologicals Business Overview
7.12.3 Novus Biologicals ADAM10 Antibody Major Product Offerings
7.12.4 Novus Biologicals ADAM10 Antibody Revenue in Global Market (2018-2023)
7.12.5 Novus Biologicals Key News & Latest Developments
7.13 R and D Systems
7.13.1 R and D Systems Company Summary
7.13.2 R and D Systems Business Overview
7.13.3 R and D Systems ADAM10 Antibody Major Product Offerings
7.13.4 R and D Systems ADAM10 Antibody Revenue in Global Market (2018-2023)
7.13.5 R and D Systems Key News & Latest Developments
7.14 Alomone Labs
7.14.1 Alomone Labs Company Summary
7.14.2 Alomone Labs Business Overview
7.14.3 Alomone Labs ADAM10 Antibody Major Product Offerings
7.14.4 Alomone Labs ADAM10 Antibody Revenue in Global Market (2018-2023)
7.14.5 Alomone Labs Key News & Latest Developments
7.15 Affinity Biosciences
7.15.1 Affinity Biosciences Company Summary
7.15.2 Affinity Biosciences Business Overview
7.15.3 Affinity Biosciences ADAM10 Antibody Major Product Offerings
7.15.4 Affinity Biosciences ADAM10 Antibody Revenue in Global Market (2018-2023)
7.15.5 Affinity Biosciences Key News & Latest Developments
7.16 Proteintech Group
7.16.1 Proteintech Group Company Summary
7.16.2 Proteintech Group Business Overview
7.16.3 Proteintech Group ADAM10 Antibody Major Product Offerings
7.16.4 Proteintech Group ADAM10 Antibody Revenue in Global Market (2018-2023)
7.16.5 Proteintech Group Key News & Latest Developments
7.17 Miltenyi Biotec
7.17.1 Miltenyi Biotec Company Summary
7.17.2 Miltenyi Biotec Business Overview
7.17.3 Miltenyi Biotec ADAM10 Antibody Major Product Offerings
7.17.4 Miltenyi Biotec ADAM10 Antibody Revenue in Global Market (2018-2023)
7.17.5 Miltenyi Biotec Key News & Latest Developments
7.18 Enzo Life Sciences
7.18.1 Enzo Life Sciences Company Summary
7.18.2 Enzo Life Sciences Business Overview
7.18.3 Enzo Life Sciences ADAM10 Antibody Major Product Offerings
7.18.4 Enzo Life Sciences ADAM10 Antibody Revenue in Global Market (2018-2023)
7.18.5 Enzo Life Sciences Key News & Latest Developments
7.19 Biobyt
7.19.1 Biobyt Company Summary
7.19.2 Biobyt Business Overview
7.19.3 Biobyt ADAM10 Antibody Major Product Offerings
7.19.4 Biobyt ADAM10 Antibody Revenue in Global Market (2018-2023)
7.19.5 Biobyt Key News & Latest Developments
7.20 Sino Biological
7.20.1 Sino Biological Company Summary
7.20.2 Sino Biological Business Overview
7.20.3 Sino Biological ADAM10 Antibody Major Product Offerings
7.20.4 Sino Biological ADAM10 Antibody Revenue in Global Market (2018-2023)
7.20.5 Sino Biological Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

 
Choose License Type

Single User : $3250


Corporate User : $4225


Why Choose Us ?

24/7 Research support

Quality assurance

Information security

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Subscribe Newsletter

  Subscribe